Hikal Reports Strong Financial Performance in May 2025, Indicating Growth Potential

Hikal, a midcap player in the Pharmaceuticals & Drugs industry, has reported very positive financial results for the quarter ending March 2025. The company announced its financial results on May 14, 2025, showcasing significant advancements in various metrics.
Notably, Hikal's Profit Before Tax (PBT) reached Rs 67.80 crore, reflecting a substantial growth compared to the average of the previous four quarters. Similarly, Profit After Tax (PAT) stood at Rs 50.20 crore, marking a remarkable increase over the same period. The company's operating profit also demonstrated strength, with an operating profit margin of 22.34%, the highest recorded in the last five quarters, indicating improved efficiency in operations.

In terms of sales, Hikal achieved net sales of Rs 552.40 crore, which is the highest in the last five quarters and shows a positive trend compared to prior averages. The company's ability to manage interest payments has also shown improvement, with an operating profit to interest ratio of 6.89 times.

Overall, Hikal's recent financial performance reflects a strong upward trajectory across key metrics, leading to an adjustment in its evaluation.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.